They've already announced they won't be putting in any effort into Bard till the case is resolved. That would include wasting time on a feasibility study.. I'm happy to let them get on with their work. They've proven their ability to achieve results already.
today's dip seems to be part of a general biotech dip..
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program, page-32
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.035(6.25%) |
Mkt cap ! $65.61M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 59.5¢ | 56.0¢ | $20.62K | 36.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 446 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 30002 | 3 |
View Market Depth
| Last trade - 15.57pm 23/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |